Inhibition of the NFκB pathway on HA-BrC cells

NE Nancy Adriana Espinoza-Sánchez
JE Jennifer Enciso
RP Rosana Pelayo
EF Ezequiel M. Fuentes-Pananá
request Request a Protocol
ask Ask a question
Favorite

To inhibit the NFκB pathway in HA-BrC cells HS578T and MDA-MB-231, we used the selective IKKα and IKKβ inhibitor ACHP from Tocris Bio-techne brand (REF 4547) [67]. ACHP was prepared as a 20 mM stock solution in dimethyl sulfoxide (DMSO) and stored at −70° C until use. 2 × 106 cells of HS578T and MDA-MB-231 were plated in 182 cm2 flasks in their standard supplemented medium, supernatants were discarded 24 hours later and cells were rinsed with PBS 1×, adding 30 mL of their respective culture media without FBS plus 16 nM/mL of ACHP. After 48 hours of culture, CMs were harvested, centrifuged at 1500 rpm/5 minutes, aliquoted, and stored at −20° C until use. As controls, we obtained CMs from cells cultures without ACHP. In order to generate a transient defective signal from the canonical NFkB pathway, we also transfected Hs578T and MDA-MB-231 cells with a plasmid vector expressing a dominant-negative IκB (mutated at serine 32 and 36) [68]. 24 hours after transfection, cells were washed with PBS 1×, after which we added their respective culture media without FBS. After 48 hours of culture, CMs were harvested, centrifuged at 1500 rpm/5 minutes, aliquoted, and stored at −20° C until use. MCF-7 and T47D cells were cultured with 3 mL of CM of HA-BrC cells cultured with ACHP or 3 mL of CM of HA-BrC cells transfected with the dominant negative IκB mutant. After incubation for 72 hours, MCF-7 and T47D cells were harvested and the induced invasive/stemness phenotype was evaluated.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A